Opioid addiction treatment centers partner with emocha for video DOT
Office-based buprenorphine treatment (OBOT) programs significantly expand access to care, but providers lack the capacity to administer the support and monitoring patients need. Direct observation is the standard of care for methadone clinics, but there are insufficient clinics to support the care needs of over 2 million patients with opioid use disorders. Many people choose not to seek treatment in such settings for several reasons, including fear of stigmatization.
Medication assisted treatment (MAT) can be delivered with unsupervised doses of buprenorphine, but providers typically don't have visibility or insight into patient adherence. Diversion and care retention present barriers to scaling office-based buprenorphine programs to combat the opioid epidemic.
Our platform offers a low-cost adherence solution.
Patients report side effects and cravings data throughout the duration of treatment. This data is tracked and visualized on a provider portal, along with adherence analytics.
With secure video recordings of each dose of medication taken, providers feel more confident that patients are properly taking their medication.
The US Department of Health and Human Services' ruling on 42 CFR 8 authorizes a single provider to treat up to 275 patients with buprenorphine at any given time. Our provider portal helps to reduce barriers to providing patient-centered care at scale.
Frequently Asked Questions
Who uses video DOT for OBOT? Private clinics and academic medical centers use video DOT to help secure adherence. OBOT programs are using this technology at private clinics, through a formal study at the University of Washington and Boston University made possible by the National Institute of Drug Abuse (NIDA) Small Business Innovation Research program (SBIR).
My patients live chaotic lives, will video DOT work? Yes, video DOT is an effective adherence strategy for complex populations, but it isn’t a one-size-fits-all solution. While some patients require frequent in-person support, video DOT can serve as a complement to treatment.
- (Learn more) HIPAA and 42 CFR Part 2-compliant
- Patient app available in 20+ languages
- Custom notifications for patients and providers
- Patients can report side effects at every dose
- View patient- and population-level analytics
- Full training and 24/7 support for patients and providers